Vanguard Group Inc. Sells 1,014,360 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Vanguard Group Inc. lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 5.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,301,061 shares of the company’s stock after selling 1,014,360 shares during the quarter. Vanguard Group Inc. owned about 11.18% of Option Care Health worth $639,622,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of OPCH. Bessemer Group Inc. raised its holdings in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after buying an additional 599 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after buying an additional 332 shares in the last quarter. Wealthquest Corp purchased a new position in shares of Option Care Health during the 1st quarter valued at about $66,000. Farther Finance Advisors LLC raised its holdings in shares of Option Care Health by 434.8% during the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company’s stock valued at $67,000 after buying an additional 1,561 shares in the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in shares of Option Care Health during the 4th quarter valued at about $47,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $28.53 on Thursday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The business’s 50 day simple moving average is $30.44 and its two-hundred day simple moving average is $31.89. The stock has a market capitalization of $4.63 billion, a P/E ratio of 22.82, a price-to-earnings-growth ratio of 1.80 and a beta of 0.79. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same period in the previous year, the firm earned $0.30 EPS. The business’s quarterly revenue was up 15.4% on a year-over-year basis. Analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on OPCH shares. JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a report on Thursday, July 31st. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. Barrington Research reissued an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. Finally, UBS Group raised Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.